Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3045% below fair value
$152.48+3.19 (+2.14%)
Close on Nov 13, 2026Market cap $10.58BP/E 24.8Yield –
Insulet operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Insulet's operating cash flow for the twelve months ending Sep 30, 2026 was $509.00M, down 4.6% year over year. For fiscal 2025 it was $569.30M, up 32.3% from the year before. The highest annual figure on record is $569.30M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $569.30M | +32.3% |
| FY2024 | Dec 31, 2024 | $430.20M | +195.3% |
| FY2023 | Dec 31, 2023 | $145.70M | +22.4% |
| FY2022 | Dec 31, 2022 | $119.00M | – |
| FY2021 | Dec 31, 2021 | -$68.10M | -181.1% |
| FY2020 | Dec 31, 2020 | $84.00M | -14.6% |
| FY2019 | Dec 31, 2019 | $98.40M | +174.1% |
| FY2018 | Dec 31, 2018 | $35.90M | -13.1% |
| FY2017 | Dec 31, 2017 | $41.30M | +159.6% |
| FY2016 | Dec 31, 2016 | $15.91M | – |
| FY2015 | Dec 31, 2015 | -$12.55M | -240.7% |
| FY2014 | Dec 31, 2014 | $8.92M | +166.4% |
| FY2013 | Dec 31, 2013 | $3.35M | – |
| FY2012 | Dec 31, 2012 | -$29.06M | – |
| FY2011 | Dec 31, 2011 | -$25.45M | – |
| FY2010 | Dec 31, 2010 | -$35.63M | – |
| FY2009 | Dec 31, 2009 | -$49.32M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $123.50M | -1.8% |
| Q2 FY2026 | Jun 30, 2026 | $88.40M | -55.0% |
| Q1 FY2026 | Mar 31, 2026 | $113.80M | +78.4% |
| Q4 FY2025 | Dec 31, 2025 | $183.30M | +24.3% |
| Q3 FY2025 | Sep 30, 2025 | $125.70M | +16.1% |
| Q2 FY2025 | Jun 30, 2025 | $196.50M | +126.4% |
| Q1 FY2025 | Mar 31, 2025 | $63.80M | -27.2% |
| Q4 FY2024 | Dec 31, 2024 | $147.50M | +226.3% |
| Q3 FY2024 | Sep 30, 2024 | $108.30M | +93.4% |
| Q2 FY2024 | Jun 30, 2024 | $86.80M | +97.3% |
| Q1 FY2024 | Mar 31, 2024 | $87.60M | +17420.0% |
| Q4 FY2023 | Dec 31, 2023 | $45.20M | -10.8% |
| Q3 FY2023 | Sep 30, 2023 | $56.00M | -1.2% |
| Q2 FY2023 | Jun 30, 2023 | $44.00M | +73.9% |
| Q1 FY2023 | Mar 31, 2023 | $500.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $50.70M | – |
| Q3 FY2022 | Sep 30, 2022 | $56.70M | – |
| Q2 FY2022 | Jun 30, 2022 | $25.30M | +38.3% |
| Q1 FY2022 | Mar 31, 2022 | -$13.70M | – |
| Q4 FY2021 | Dec 31, 2021 | -$25.50M | -250.0% |
| Q3 FY2021 | Sep 30, 2021 | -$25.80M | -158.4% |
| Q2 FY2021 | Jun 30, 2021 | $18.30M | -30.7% |
| Q1 FY2021 | Mar 31, 2021 | -$35.10M | – |
| Q4 FY2020 | Dec 31, 2020 | $17.00M | -63.8% |
| Q3 FY2020 | Sep 30, 2020 | $44.20M | +42.1% |
| Q2 FY2020 | Jun 30, 2020 | $26.40M | +89.9% |
| Q1 FY2020 | Mar 31, 2020 | -$3.60M | -155.4% |
| Q4 FY2019 | Dec 31, 2019 | $46.90M | +54.1% |
| Q3 FY2019 | Sep 30, 2019 | $31.10M | +96.2% |
| Q2 FY2019 | Jun 30, 2019 | $13.90M | – |
| Q1 FY2019 | Mar 31, 2019 | $6.50M | – |
| Q4 FY2018 | Dec 31, 2018 | $30.44M | +39.0% |
| Q3 FY2018 | Sep 30, 2018 | $15.86M | -31.9% |
| Q2 FY2018 | Jun 30, 2018 | -$6.13M | -134.1% |
| Q1 FY2018 | Mar 31, 2018 | -$4.27M | – |
| Q4 FY2017 | Dec 31, 2017 | $21.89M | +9.1% |
| Q3 FY2017 | Sep 30, 2017 | $23.28M | – |
| Q2 FY2017 | Jun 30, 2017 | $17.96M | – |
| Q1 FY2017 | Mar 31, 2017 | -$21.84M | – |
| Q4 FY2016 | Dec 31, 2016 | $20.07M | – |
See a number that looks wrong?